1. OnabotulinumtoxinA Is Efficacious and Well Tolerated in Male Patients With Overactive Bladder and Urinary Incontinence: Placebo-Controlled Treatment Cycle 1 Results From a Pooled Analysis of Four Randomized Trials. (July 2022) Authors: Nitti, V.; Ginsberg, D.A.; Kohan, A.; McCammon, K.; Jenkins, B.; Yushmanova, I.; Boroujerdi, A.; Chapple, C. Journal: Toxicon Issue: Volume 214(2022)Supplement 1 Page Start: S44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗